Remove Atherosclerosis Remove Diabetes Remove Obesity
article thumbnail

How Apob & Visceral Fat Increase Your Risk Of Heart Disease.

Dr. Paddy Barrett

ApoB Atherosclerosis, by definition, is caused by the retention of an ApoB lipid particle in the artery wall. This retained particle then sets off an inflammatory cascade, which ultimately results in the formation of atherosclerosis 1. Mechanism of atherosclerosis formation. Relationship of BMI and Risk Of Diabetes.

article thumbnail

Your Top Five Questions About CMHC On-Demand, Answered

Cardiometabolic Health Congress

Obesity: Learn about behavioral approaches, the latest in pharmacotherapy, and surgical interventions for managing obesity. Diabetes Management: Gain insights into precision medicine, advanced insulin therapies, and continuous glucose monitoring (CGM) for cardiovascular risk assessment.

CME 52
article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 100
article thumbnail

Researchers Find ApoB Test May be More Accurate Measure of Heart Disease Risk

DAIC

This happens more commonly in people with metabolic risk factors such as obesity, diabetes, or high triglycerides. guidelines may overlook people who are at higher risk of developing atherosclerosis despite normal metabolic health markers. But even people without these conditions can have discordance. population.

article thumbnail

Multi-Ethnic Study of Atherosclerosis Early Heart Failure Study: Rationale, Design, and Baseline Characteristics

Circulation: Heart Failure

The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Results:Median age was 73 (25th–75th percentile 67–81) years, 53.2% were female, 25.6% were Black, 12.8% were Chinese, and 40.0% were White.

article thumbnail

Atherogenic circulating lipoproteins in ischemic stroke

Frontiers in Cardiovascular Medicine

The fundamental role of qualitative alterations of lipoproteins in the early development of atherosclerosis has been widely demonstrated. However, the corresponding studies are scarcer in the field of ischemic stroke, despite carotid arteriosclerosis progression underlies at least 20% of ischemic strokes.

article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Experts like Louis J.

CME 64